Posted on October 31st, 2011 by
A drug which should have great potential in helping to minimise the effects of the blinding condition macular degeneration may have some side-effects, according to one researcher in the US. Mayo Clinic scientist Dr Sophie Bakri has found that the Food and Drug Administration-approved ranibizumab (Lucentis) may be increasing pressure inside some patients" eyes.
Contact Lenses (UK), Adrian Galbreth, 10/31/11
You must be logged-in to the site to post a comment.